Strategy Asset Managers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $313K | Buy |
3,999
+556
| +16% | +$44.9K | 0.05% | 217 |
|
|
2026
Q1 | $298K | Sell |
3,443
-22
| -0.6% | -$2.11K | 0.05% | 214 |
|
|
2025
Q4 | $333K | Buy |
3,465
+26
| +0.8% | +$2.53K | 0.05% | 195 |
|
|
2025
Q3 | $327K | Sell |
3,439
-16
| -0.5% | -$1.47K | 0.06% | 198 |
|
|
2025
Q2 | $301K | Sell |
3,455
-719
| -17% | -$61K | 0.06% | 199 |
|
|
2025
Q1 | $375K | Buy |
4,174
+344
| +9% | +$30.8K | 0.08% | 180 |
|
|
2024
Q4 | $306K | Sell |
3,830
-33,103
| -90% | -$2.87M | 0.06% | 202 |
|
|
2024
Q3 | $3.33M | Sell |
36,933
-8,685
| -19% | -$731K | 0.64% | 47 |
|
|
2024
Q2 | $4.02M | Buy |
45,618
+8,074
| +22% | +$662K | 0.89% | 35 |
|
|
2024
Q1 | $3.27M | Buy |
37,544
+15,713
| +72% | +$1.34M | 0.7% | 43 |
|
|
2023
Q4 | $1.8M | Sell |
21,831
-12,394
| -36% | -$945K | 0.43% | 53 |
|
|
2023
Q3 | $2.68M | Sell |
34,225
-11,393
| -25% | -$954K | 0.7% | 40 |
|
|
2023
Q2 | $4.02M | Buy |
45,618
+5,786
| +15% | +$498K | 0.89% | 35 |
|
|
2023
Q1 | $3.21M | Buy |
39,832
+5,051
| +15% | +$412K | 0.78% | 40 |
|
|
2022
Q4 | $2.7M | Buy |
34,781
+59
| +0.2% | +$4.78K | 0.69% | 39 |
|
|
2022
Q3 | $2.8M | Buy |
34,722
+3,165
| +10% | +$284K | 0.76% | 40 |
|
|
2022
Q2 | $2.83M | Sell |
31,557
-1,132
| -3% | -$115K | 0.87% | 33 |
|
|
2022
Q1 | $3.63M | Buy |
32,689
+1,062
| +3% | +$112K | 0.78% | 37 |
|
|
2021
Q4 | $3.27M | Sell |
31,627
-4,581
| -13% | -$530K | 0.85% | 37 |
|
|
2021
Q3 | $4.54M | Buy |
36,208
+822
| +2% | +$106K | 1.01% | 33 |
|
|
2021
Q2 | $4.39M | Buy |
35,386
+1,095
| +3% | +$137K | 0.93% | 36 |
|
|
2021
Q1 | $4.05M | Sell |
34,291
-59
| -0.2% | -$6.92K | 0.93% | 36 |
|
|
2020
Q4 | $4.02M | Sell |
34,350
-2,192
| -6% | -$241K | 0.96% | 36 |
|
|
2020
Q3 | $3.8M | Sell |
36,542
-1,326
| -4% | -$133K | 0.98% | 37 |
|
|
2020
Q2 | $3.47M | Sell |
37,868
-324
| -0.8% | -$31.1K | 0.93% | 33 |
|
|
2020
Q1 | $3.44M | Sell |
38,192
-894
| -2% | -$95.1K | 1.11% | 32 |
|
|
2019
Q4 | $4.43M | Buy |
39,086
+2,240
| +6% | +$246K | 1.09% | 28 |
|
|
2019
Q3 | $4M | Sell |
36,846
-1,304
| -3% | -$136K | 1.19% | 25 |
|
|
2019
Q2 | $3.71M | Buy |
38,150
+6,217
| +19% | +$568K | 1.05% | 28 |
|
|
2019
Q1 | $2.91M | Buy |
31,933
+9,376
| +42% | +$839K | 0.65% | 39 |
|
|
2018
Q4 | $2.05M | Buy |
+22,557
| New | +$2.11M | 0.5% | 57 |
|
Other funds holding MDT
Strategy Asset Managers's MDT Position: Q2 2026 in Review
Strategy Asset Managers increased its Medtronic (MDT) stake by 16% in Q2 2026, buying an estimated $44.9K and bringing the position to 3,999 shares worth $313K. The position accounts for 0.05% of the portfolio, ranked #217.
Strategy Asset Managers first reported a position in MDT in Q4 2018 and has held it in 31 quarters since. The position peaked at $4.54M in Q3 2021. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Strategy Asset Managers held 3,999 shares of Medtronic worth $313K as of Q2 2026.
- Strategy Asset Managers bought 556 Medtronic shares in Q2 2026, an estimated $44.9K.
- Medtronic made up 0.05% of Strategy Asset Managers's portfolio in Q2 2026, its #217 holding.
- Strategy Asset Managers first reported a position in Medtronic in Q4 2018 and has held it in 31 quarters since.
- Strategy Asset Managers's Medtronic position peaked at $4.54M in Q3 2021.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Strategy Asset Managers's 13F filing for Q2 2026, filed 14 Aug 2026.